GlassScriptPhysician profile
Mary Thi Tran
NPI 1891319646
$7,749.75
in general payments reported to CMS, 2019-2025
41 companies · $2,886 in 2025
The $2,886 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $817 · 2024: $4,047 · 2025: $2,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,826 · Consulting Fee: $1,020 · Travel and Lodging: $689 · Education: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,825.82 |
| Consulting Fee | $1,020.00 |
| Travel and Lodging | $689.43 |
| Education | $214.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,430.66 | 2024-2025 | Inspire |
| Ucb, INC. | $1,253.74 | 2024 | Cimzia, Bimzelx |
| Astrazeneca Pharmaceuticals LP | $575.97 | 2023-2025 | Tezspire, Saphnelo, Airsupra |
| Abbvie INC. | $560.22 | 2023-2025 | |
| Zynex Medical, INC. | $510.55 | 2023 | Nexwave |
| Amgen INC. | $458.83 | 2024-2025 | Evenity, Enbrel, Tezspire |
| Jazz Pharmaceuticals INC. | $430.01 | 2025 | |
| Janssen Biotech, INC. | $349.44 | 2024-2025 | Tremfya, Simponi Aria |
| Regeneron Healthcare Solutions, INC. | $176.29 | 2024-2025 | Dupixent |
| Genentech USA, INC. | $169.79 | 2024-2025 | Actemra |
| Genzyme Corporation | $168.42 | 2024-2025 | |
| Radius Health, INC. | $129.33 | 2023-2024 | Tymlos |
| Novartis Pharmaceuticals Corporation | $113.73 | 2025 | |
| Glaxosmithkline, LLC. | $107.39 | 2025 | Nucala, Trelegy Ellipta |
| Fisher & Paykel Healthcare INC | $90.91 | 2025 | Fisher & Paykel Healthcare |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.